When separated into young and octogenarian groups, no differences were seen in variables associated with bleeding complications, which matched the overall cohort (female sex, radial access, GP IIb/IIIa inhibitor use, previous stroke, peripheral vascular disease, and intra‐aortic balloon pump use). The gene discussed is ITGA2B; the disease is peripheral vascular disease.